Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
5
NCT02994563
Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study
Phase: N/A
Role: Lead Sponsor
Start: Oct 7, 2019
Completion: Mar 1, 2021